On 2025-11-12, BridgeBio Oncology Therapeutics, Inc (BBOT) announced earnings per share of $-1.03 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-0.41.

The next expected annoucement date for quarterly earnings is 2026-02-11, with an average estimated earnings per share of $-0.44 for the fiscal quarter ending 2025-12-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.